Group 1 - CME Group is planning to launch the world's first futures contract in rare earth, which would enable various parties to hedge exposure in a sector dominated by China [1][3] - The proposed contract would be linked to neodymium and praseodymium (NdPR), essential elements for permanent magnets used in electric vehicles, wind turbines, drones, and advanced weapon systems [2][5] - The goal of the contract is to establish a transparent and liquid pricing benchmark outside of China, facilitating hedging for producers, consumers, and financiers, potentially unlocking funding for Western mining and processing projects [3][4] Group 2 - The rare earth market is currently small and thinly traded compared to other metals, and no final decision has been made regarding the contract launch [4] - China holds a dominant position in the rare earth sector, accounting for approximately 90% of global processing capacity, which has implications for U.S.-China trade relations [6] - Recent trade tensions have led to China imposing export controls on critical minerals, although some measures were suspended as part of a broader truce, effective until November 10, 2026 [7]

Market Overview - U.S. stock futures rose on Thursday following a decline on Wednesday, driven by a strong January jobs report [1] - The Dow Jones index declined after a record-high close on Tuesday [1] - The 10-year Treasury bond yield was at 4.175%, while the two-year bond yield was at 3.502% [1] - The CME Group's FedWatch tool indicates a 94.1% likelihood of the Federal Reserve keeping interest rates unchanged in March [1] Index Performance - Dow Jones increased by 0.21% [2] - S&P 500 rose by 0.23% [2] - Nasdaq 100 gained 0.17% [2] - Russell 2000 saw an increase of 0.39% [2] Stocks in Focus - Micron (MU) maintains a strong price trend across short, medium, and long terms according to Benzinga's Edge Stock Rankings [2] - Novocure (NVCR) shows a strong price trend in the short and medium terms but a weaker trend in the long term [3] - Fastly (FSLY) maintains a strong price trend across all time frames [4] - McDonald's (MCD) also shows a strong price trend across short, medium, and long terms [5] - Applovin (APP) has a weak price trend across all time frames [6] Analyst Insights - Analysts at the Schwab Center for Financial Research noted that investors are awaiting the Consumer Price Index (CPI) release [7] - The market is pricing out rate cuts for this year following the jobs report [7] - The likelihood of a Federal Reserve rate cut next month dropped to 6% from 20% earlier in the week, with less than 60% chance of at least one rate cut by June [8] Economic Data - The three-month average of nonfarm payroll growth increased to 73,000 in January, the highest since February 2025 [9]

Market Overview - U.S. stock futures rose on Thursday following a decline on Wednesday, driven by a strong January jobs report [1] - The Dow Jones index declined on Wednesday after reaching a record-high close on Tuesday [1] - The 10-year Treasury bond yield was at 4.175%, while the two-year bond yield was at 3.502% [1] - The CME Group's FedWatch tool indicates a 94.1% likelihood of the Federal Reserve keeping interest rates unchanged in March [1] Index Performance - Dow Jones increased by 0.21% [2] - S&P 500 rose by 0.23% [2] - Nasdaq 100 gained 0.17% [2] - Russell 2000 saw an increase of 0.39% [2] Stocks in Focus - Micron (MU) maintains a strong price trend across short, medium, and long terms according to Benzinga's Edge Stock Rankings [2] - Novocure (NVCR) shows a strong price trend in the short and medium terms but a weaker trend in the long term [3] - Fastly (FSLY) maintains a strong price trend across all time frames [4] - McDonald's (MCD) also shows a strong price trend across short, medium, and long terms [5] - Applovin (APP) has a weak price trend across all time frames [6] Analyst Insights - Analysts at the Schwab Center for Financial Research noted that investors are awaiting the Consumer Price Index (CPI) release [7] - The market is pricing out rate cuts for this year following the jobs report [7] - The likelihood of a Federal Reserve rate cut next month has dropped to 6% from 20% earlier in the week [8] - The chances of at least one rate cut by June are now below 60%, down from 75% [8] - The three-month average of nonfarm payroll growth increased to 73,000 in January, the highest since February 2025 [9] Commodities and Global Markets - Crude oil futures rose by 0.36% to approximately $64.86 per barrel [11] - Gold Spot declined by 0.47% to around $5,059.50 per ounce, with a previous record high of $5,595.46 per ounce [11] - The U.S. Dollar Index increased by 0.03% to 96.8610 [11] - Bitcoin traded 0.15% higher at $66,906.94 per coin [11] Upcoming Economic Data - Initial jobless claims data for the week ending February 7 will be released at 8:30 a.m. ET [12] - January's existing home sales data will be available at 10:00 a.m. ET [12] - Fed governor Stephen Miran is scheduled to speak at 7:00 p.m. ET [12]

Core Insights - The consumer discretionary sector has identified oversold stocks that present potential buying opportunities for undervalued companies [1] Group 1: Oversold Stocks - Major oversold players in the consumer discretionary sector have a Relative Strength Index (RSI) near or below 30, indicating potential undervaluation [1] - Companies such as Papa John's International Inc (NASDAQ:PZZA) and Wayfair Inc (NYSE:W) are highlighted as part of this oversold list [2]

Core Insights - The consumer discretionary sector has identified oversold stocks that present potential buying opportunities for undervalued companies [1] Group 1: Oversold Stocks - Major oversold players in the consumer discretionary sector have a Relative Strength Index (RSI) near or below 30, indicating potential undervaluation [1] - Companies such as Papa John's International Inc (NASDAQ:PZZA) and Wayfair Inc (NYSE:W) are highlighted as significant oversold stocks in this sector [2]

Group 1: Company Strategy and Goals - Novo Nordisk aims to reach approximately 15 million new patients when Medicare begins covering obesity treatments later this year [1] - CEO Mike Doustdar indicated that the expansion of Medicare coverage for obesity treatments is expected to be slow, with a realistic outlook on adoption rates [1] - The company is currently in negotiations with the government to finalize the timing for the opening of Medicare coverage [2] Group 2: Market Dynamics and Pricing - Wegovy pills are listed at $149 on the newly launched TrumpRx website, representing an 89% discount from prevailing market prices, while Wegovy and Ozempic pens start at $199 each [3] - Eli Lilly's Zepbound is priced from $299 per vial, reflecting an estimated 72% discount [3] - Medicare and Medicaid coverage for GLP-1 obesity treatments is set to expand starting in mid-2026, with a $50 copay required from patients [4] Group 3: Competitive Landscape - Eli Lilly anticipates revenue of $80–$83 billion, exceeding Wall Street's forecast of $77.62 billion, indicating a 25% growth [5] - Novo Nordisk's stock has declined by 40.41% over the past year, closing at $48.74 after a 0.77% drop [6] - Benzinga's Edge Rankings place Novo Nordisk in the 77th percentile for quality and the 31st percentile for value, highlighting its mixed performance compared to peers [5]

Group 1: Stock Performance - Greenlane Holdings Inc. shares surged 71.72% to $1.58 in after-hours trading, despite closing regular trading at $0.92, down 7.05% [1] - The stock has experienced a staggering decline of 99.90% over the past 12 months, with a market capitalization of $7.33 million [4] - Currently, the stock is positioned just above its 52-week low, roughly 0.002% above the bottom of its annual range [4] Group 2: Company Developments - Greenlane Holdings announced a Berachain-focused digital asset treasury strategy in late January [3] - A wholly owned subsidiary of Greenlane signed a Token Purchase and Sale Agreement and a Token Lending Agreement with Berachain Operations Corporation [2]

Zoetis Inc. (NYSE:ZTS) will release earnings for its fourth quarter before the opening bell on Thursday, Feb. 12.Analysts expect the Parsippany, New Jersey-based company to report quarterly earnings at $1.4 per share, compared to $1.4 per share in the year-ago period. The consensus estimate for Zoetis quarterly revenue is $2.36 billion (it reported $2.32 billion last year), according to Benzinga Pro.On Dec. 16, Zoetis announced pricing of $1.75 billion convertible senior notes offering.Shares of Zoetis rose ...

Core Viewpoint - Zoetis Inc. is expected to report stable earnings and revenue for its fourth quarter, with analysts projecting earnings per share to remain at $1.4 and revenue to increase slightly to $2.36 billion from $2.32 billion in the previous year [1][2]. Financial Performance - The anticipated earnings per share for Zoetis in the fourth quarter is $1.4, consistent with the same period last year [1]. - The consensus estimate for quarterly revenue is $2.36 billion, reflecting a growth from $2.32 billion reported in the previous year [1]. Recent Developments - On December 16, Zoetis announced the pricing of a $1.75 billion convertible senior notes offering, indicating a significant capital-raising effort [1]. - Shares of Zoetis rose by 0.4%, closing at $128.67 on Wednesday, suggesting a positive market response [2].

Market Sentiment - The CNN Money Fear and Greed index showed a decline in overall market sentiment, remaining in the "Neutral" zone with a reading of 48.9, down from 50.9 [1][4] - U.S. stocks settled mostly lower, with the Dow Jones index falling more than 50 points, ending a three-session winning streak [1][3] Economic Data - Nonfarm payrolls rose by 130,000, nearly double the economists' expectations of 70,000, with private-sector employment contributing 172,000 of those gains [2] - The unemployment rate unexpectedly declined to 4.3% from 4.4% [2] Sector Performance - Most sectors on the S&P 500 closed positively, with energy, materials, and consumer staples stocks recording the biggest gains [2] - Financial and communication services stocks closed lower, bucking the overall market trend [2] Company Highlights - Micron Technology Inc. (NASDAQ:MU) saw a significant jump of around 10% after Morgan Stanley raised its price target to $450 [1]